JF
CUE icon

Jump Financial’s Cue Biopharma CUE Stock Holding History

Jump Financial’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,430
Closed -$157K – 1916
2023
Q2 		$157K Buy
+1,430
New +$168K 0.01% 1570
2023
Q1 		– Sell
-388
Closed -$33.1K – 1672
2022
Q4 		$33.1K Buy
+388
New +$35.5K ﹤0.01% 1511
2022
Q3 		– Sell
-1,177
Closed -$88K – 1645
2022
Q2 		$88K Buy
1,177
+334
+40% +$39.1K ﹤0.01% 1456
2022
Q1 		$123K Buy
+843
New +$179K 0.01% 1388

Other funds holding CUE

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jump Financial's CUE Position: Q3 2023 in Review

Jump Financial sold out of Cue Biopharma (CUE) in Q3 2023, closing a stake of 1,430 shares — an estimated $157K sold.

Jump Financial first reported a position in CUE in Q1 2022 and held it in 4 quarters. The position peaked at $157K in Q2 2023. 75 funds tracked by Wall St. Rank hold CUE as of Q3 2023.

  • Jump Financial reported no remaining Cue Biopharma position as of Q3 2023 after selling out during the quarter.
  • Jump Financial sold 1,430 Cue Biopharma shares in Q3 2023, an estimated $157K.
  • Jump Financial first reported a position in Cue Biopharma in Q1 2022 and held it in 4 quarters.
  • Jump Financial's Cue Biopharma position peaked at $157K in Q2 2023.
  • 75 funds tracked by Wall St. Rank held Cue Biopharma as of Q3 2023.

Based on Jump Financial's 13F filing for Q3 2023, filed 7 Nov 2023.